Distinguished rheumatologist Prof. Sukumar Mukherjee, a mentor at Suraksha Diagnostics and a renowned expert in the field with over 35 years of experience, graced the grand opening of one of the largest and most advanced genomics labs in Eastern India.

West Bengal is a cultural and educational leader in the nation, and the state is currently seeing a boom in medical services and education. Suraksha Diagnostics acknowledged the pressing need for easily accessible genomic diagnostics in West Bengal in keeping with this comeback. Its genomics lab facilitates early, precise risk detection and improved treatment, which is in line with the future of preventive care.

This cutting-edge genomics lab has multiple next-generation sequencers (NGS), cytogenetics, microarray technology, and Sanger sequencing.

When combined, these technologies allow for the full range of sophisticated genetic testing, providing individualized, preventative, and predictive care.

In addition to sex chromosome aneuploidies and microdeletions, Suraksha’s Genomics Lab makes it possible to identify chromosomal abnormalities such as Patau syndrome, Edwards syndrome, and Down syndrome. With the support of professional genetic counseling, these insights assist expectant parents in making well-informed decisions.

With its cutting-edge hereditary cancer testing panels, Suraksha’s Genomics Lab also leads the way in onco-genomics, facilitating the early identification of genetic predispositions to colorectal, ovarian, and breast cancers.

In order to help with individualized cancer risk assessment and treatment planning, the lab provides both germline and somatic mutation profiling. NGS-powered targeted oncology panels have made it possible for physicians to find actionable mutations for precision treatments. As a result, Suraksha is among the few facilities in Eastern India that provide oncology diagnostics that are genuinely customized.

Karyotyping, which enables medical professionals to view all 46 chromosomes and detect extra or missing segments, is the first step in the lab’s genomics testing procedure. Chromosomal microarray scans look for minor genetic alterations for a more thorough examination, whereas FISH technology targets particular genetic problems. While Next-Generation Sequencing (NGS) analyzes millions of genetic data points and provides deeper insights into complex health conditions, Sanger Sequencing is used to precisely read individual genes.

By incorporating cutting-edge technologies into standard clinical care, Suraksha Diagnostics hopes to establish itself as a national leader in genomics-driven diagnostics. In addition to growing research and public health programs, the company hopes to support national priorities like newborn screening, rare disease diagnosis, and preventive genomics.

Priyanka Dutta